We are happy to announce that BlueClinical is a proud gold sponsor of the 2nd Bioequivalence Workshop by Medicines for Europe, which is scheduled to take place on 26 April 2023 in Brussels, Belgium.
The workshop will provide a platform for an exchange of views between industry, regulators and academia.
You may find out more on the event at: 2nd Bioequivalence Workshop
Contact us for more details or for discussing your clinical development projects at: firstname.lastname@example.org
Privacy and Data Protection Policy Update
BlueClinical is involved, through its Clinical Research Partnership Network, on the Phase 3 MORNINGSKY trial